| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Sanders MacHelle is a Director at BIOCRYST PHARMACEUTICALS INC with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $376K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | BCRX Biocryst Pharmaceuticals Inc | Director | Sell | 9,600 | $7.14 | $68,544.00 | -23.9% | -0.9% | - | |
| Jun 17, 2024 | BCRX Biocryst Pharmaceuticals Inc | Director | Sell | 4,689 | $6.00 | $28,134.00 | -14.5% | +26.8% | +59.8% | |
| Jun 15, 2023 | BCRX Biocryst Pharmaceuticals Inc | Director | Sell | 4,000 | $7.98 | $31,920.00 | -13.5% | -13.8% | -22.7% |